Saudi Arabia reportedly plans to finalize the oil transshipment scheme via the Strait of Hormuz to compete for market share.
According to sources, Saudi Arabia is in discussions with crude oil buyers and plans to complete crude oil loading outside the Strait of Hormuz starting next year, incorporating this arrangement into long-term supply contracts.
According to Golden Ten Data APP, insiders have revealed that Saudi Arabia is in talks with crude oil buyers, planning to start loading crude oil outside the Strait of Hormuz from next year, and include this arrangement in long-term supply contracts. This transfer model was implemented during the Iran conflict, and now Saudi Arabia hopes to make it a regular practice to gain greater market share.
Insiders stated that negotiations are still ongoing and need to be finalized before the end of this year. If the plan is approved, Saudi Arabia’s delivery model for crude exports will undergo major changes, since deliveries under long-term contracts account for the majority of Saudi supply.
The Iran conflict, which has lasted eight months, has disrupted traditional crude shipping routes, with serious interference in the Strait of Hormuz shipping. The main oil-exporting countries in the Gulf have had to adjust their operations to ensure client supply. As competition among buyers intensifies, the Hormuz Strait transshipment model has become a key mechanism to safeguard market supply: sellers bear the risks of sailing through the Strait, transferring crude to other tankers outside the Strait.
According to the aforementioned insiders, Saudi Aramco is also discussing other adjustments, including offering pricing benchmark options and even directly delivering cargo to Asian customers. No final decision has been made yet, and details such as pricing, freight, and available oil volume are still being discussed.
Both Saudi Aramco and Saudi Ministry of Energy have not responded to requests for comment regarding the negotiations.
It is understood that prior to the conflict, Saudi Aramco’s core Asian clients arranged their own tankers and picked up shipments at the Ras Tanura export terminal deep within the Persian Gulf, with shipping arrangements generally not handled by Saudi Arabia.
After the conflict erupted, some shipowners became unwilling to enter the Strait of Hormuz. Even with ample crude supply, buyers struggled to charter tankers at reasonable costs. Under such circumstances, the UAE, Saudi Arabia, Kuwait, and Iraq adopted the Hormuz transfer solution, completing crude deliveries outside the Strait through ship-to-ship transfers.
Insiders say Saudi Aramco has been supplying its three main crude grades—Arab Light, Medium, and Heavy—using this transfer mechanism.
Other sources revealed that recently Saudi Aramco has allowed some buyers to conduct ship-to-ship crude transfers offshore India. For clients unable to enter the Gulf of Oman due to safety concerns, this is a relatively safe alternative and also helps ease congestion at ports on the Arabian Peninsula.
Insiders stated that Saudi Aramco is also studying shipping arrangement plans, exploring more direct crude delivery to customers. In addition to ensuring smooth exports, such plans also allow Saudi Aramco to share in some of the gains caused by surging tanker rental prices through the Strait of Hormuz.
Sources say some Asian buyers are negotiating with Saudi Aramco to switch their long-term contract crude purchases to Brent futures pricing, replacing the current Dubai and Oman benchmark prices. This would give the Gulf oil producer more pricing flexibility.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
CleanTech Lithium expands foothold in Argentina
BUZZ-Better Home & Finance shares rise after announcing a $30 million stock buyback plan
October 8 - Better Home & Finance (BETR.O), a mortgage and home equity financing company, saw its stock price rise 3.8% to $10.30 in pre-market trading after announcing a share repurchase plan. BETR stated that its board of directors has approved a stock buyback program of up to $30 million, with an initial phase of $10 million to kick off the repurchase. The company plans to adjust the pace of the repurchase based on realized operational cost savings and asset disposal progress, such as the proposed sale of its UK bank subsidiary. The buyback program is set to expire on October 8, 2027. In August, BETR forecasted that its Q3 revenue would be below Wall Street expectations as it focuses on partnership opportunities and accelerating the development of its home equity credit business. As of the previous trading day's close, the company's market capitalization was approximately $175 million. As of Wednesday, the stock has dropped about 70% year-to-date. According to LSEG data, seven out of eight analysts rate the stock as "strong buy" or "buy," with one rating it as "hold"; the median target price is $25. (For the convenience of non-English speakers, Reuters provides translated automated reports in several other languages. As automated translations may contain errors or lack required context, Reuters does not guarantee the accuracy of these texts and provides them simply for convenience. Reuters accepts no liability for any damage or loss arising from the use of automated translation.)
Fed Governor Waller leaves room for hawkishness: More rate hikes are needed to support inflation decline, not necessarily on a monthly basis.
Federal Reserve Governor Waller stated that if the data meets expectations, there will be further interest rate hikes. The core PCE year-on-year rate at 3% is still too high, and the recent monetary policy focus remains on fighting inflation.
Updated: Viatris will acquire pain therapy manufacturer Pacira BioSciences for 1.65 billions dollars.
The second paragraph adds stock information, while the fifth, eighth, and ninth paragraphs provide additional details. Background information is supplemented in the sixth, seventh, tenth, and eleventh paragraphs. Reuters, October 8 – Pharmaceutical company Viatris (VTRS.O) will acquire Pacira BioSciences (PCRX.O) in an all-cash deal worth $1.65 billions, adding two non-opioid painkillers to its portfolio, the companies said on Thursday. Viatris will acquire Pacira at $36.50 per share, representing a 44.8% premium to the latest closing price. Pacira’s stock rose by 44% in premarket trading. Pacira’s non-opioid painkillers, Exparel and Zilretta, generated sales in 2025 of $575.1 millions and $116.6 millions respectively. Exparel is used to relieve acute pain after surgery, and Zilretta is used to treat pain associated with knee osteoarthritis. Viatris stated it expects to expand the reach of these products in selected target markets. Viatris CEO Scott Smith stated, “the addition of these medications creates a synergy with our rapid-acting meloxicam market opportunities, positioning us as a leader in non-opioid pain management.” The US Food and Drug Administration (FDA) is expected to make a decision by December 27 on the approval application for rapid-acting meloxicam for the treatment of moderate to severe acute pain. Viatris plans to finance the acquisition primarily with idle cash, and the remainder through short-term borrowing. The company noted the deal will have minimal impact on its total leverage ratio. In August, Viatris (link) raised its annual adjusted profit forecast, counting on strong brand drug sales and growth in the Chinese market. The pharmaceutical company had previously faced (link) production setbacks in its Indian operations, including a fire at its Nashik plant in western India and increased competition in the generic drug market, raising concerns about the resilience and growth of its core business. The company stated the transaction is expected to close by the end of 2026 and will immediately enhance Viatris’s financial guidance metrics. (For non-native English speakers, Reuters provides automated translations of its reports into several other languages. Since automated translations may contain errors or lack necessary context, Reuters does not guarantee their accuracy and provides them for convenience only. Reuters accepts no liability for any damage or loss caused by the use of automated translation.)
Crypto prices
More
